Today’s Price Action: Could UnitedHealth Group Inc Go Down After Touching 52-Week High?

Today's Price Action: Could UnitedHealth Group Inc Go Down After Touching 52 Week High?

The stock of UnitedHealth Group Inc (NYSE:UNH) hit a new 52-week high and has $160.82 target or 5.00% above today’s $153.16 share price. The 7 months bullish chart indicates low risk for the $147.01B company. The 1-year high was reported on Nov, 25 by If the $160.82 price target is reached, the company will be worth $7.35 billion more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 276,612 shares traded hands. UnitedHealth Group Inc (NYSE:UNH) has risen 14.47% since April 22, 2016 and is uptrending. It has outperformed by 9.06% the S&P500.

Analysts await UnitedHealth Group Inc (NYSE:UNH) to report earnings on January, 17. They expect $2.07 earnings per share, up 47.86% or $0.67 from last year’s $1.4 per share. UNH’s profit will be $1.99B for 18.50 P/E if the $2.07 EPS becomes a reality. After $2.17 actual earnings per share reported by UnitedHealth Group Inc for the previous quarter, Wall Street now forecasts -4.61% negative EPS growth.

UnitedHealth Group Inc (NYSE:UNH) Ratings Coverage

Out of 15 analysts covering UnitedHealth Group (NYSE:UNH), 14 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 93% are positive. UnitedHealth Group has been the topic of 20 analyst reports since September 2, 2015 according to StockzIntelligence Inc. The rating was initiated by Credit Suisse on Wednesday, December 16 with “Outperform”. The company was reinitiated on Wednesday, September 9 by Morgan Stanley. Vetr upgraded it to “Strong-Buy” rating and $128.77 target price in Wednesday, September 2 report. The rating was maintained by Mizuho on Friday, November 20 with “Buy”. The firm has “Buy” rating given on Friday, July 22 by Argus Research. The company was downgraded on Wednesday, November 9 by Mizuho. RBC Capital Markets maintained the stock with “Outperform” rating in Wednesday, July 20 report. Mizuho maintained the shares of UNH in a report on Wednesday, October 19 with “Buy” rating. FBR Capital maintained UnitedHealth Group Inc (NYSE:UNH) on Thursday, November 19 with “Outperform” rating. The company was initiated on Friday, April 8 by Cleveland.

According to Zacks Investment Research, “UnitedHealth Group Inc. offers health care coverage and related services to help people achieve improved health and well-being through all stages of life. The company’s products and services reflect a number of core capabilities, including medical information management, health benefit administration, care coordination, risk assessment and pricing, health benefit design and provider contracting. With these capabilities, it is able to provide comprehensive health care management services through organized health systems and insurance products.”

Insitutional Activity: The institutional sentiment increased to 1.02 in Q2 2016. Its up 0.10, from 0.92 in 2016Q1. The ratio is positive, as 55 funds sold all UnitedHealth Group Inc shares owned while 466 reduced positions. 94 funds bought stakes while 386 increased positions. They now own 805.88 million shares or 5.42% less from 852.02 million shares in 2016Q1.
Janus Limited Liability Corporation holds 2.91M shares or 0.35% of its portfolio. Glenview Comml Bank Trust Dept has invested 0.16% of its portfolio in UnitedHealth Group Inc (NYSE:UNH). Muhlenkamp Company holds 60,220 shares or 3.32% of its portfolio. Moreover, Liberty Capital Mngmt has 0.99% invested in UnitedHealth Group Inc (NYSE:UNH) for 10,419 shares. The Oregon-based Oregon Employees Retirement Fund has invested 0.75% in UnitedHealth Group Inc (NYSE:UNH). Vigilant Cap Management Ltd Liability holds 51,250 shares or 1.38% of its portfolio. The New York-based Ibm Retirement Fund has invested 0.64% in UnitedHealth Group Inc (NYSE:UNH). Moreover, Westpac Bk has 0% invested in UnitedHealth Group Inc (NYSE:UNH) for 377,381 shares. Cambridge Tru owns 2,400 shares or 0.03% of their US portfolio. Donaldson Capital Management Lc has invested 0.48% of its portfolio in UnitedHealth Group Inc (NYSE:UNH). Gsa Capital Llp has 0.21% invested in the company for 26,855 shares. Ranger Investment Mgmt L P has invested 0% of its portfolio in UnitedHealth Group Inc (NYSE:UNH). Paradigm Asset Mgmt Lc has invested 0% of its portfolio in UnitedHealth Group Inc (NYSE:UNH). Thomas J Herzfeld Advisors holds 0.05% of its portfolio in UnitedHealth Group Inc (NYSE:UNH) for 689 shares. Citizens & Northern, a Pennsylvania-based fund reported 2,703 shares.

Insider Transactions: Since June 10, 2016, the stock had 0 insider purchases, and 6 insider sales for $9.57 million net activity. 5,460 UnitedHealth Group Inc (NYSE:UNH) shares with value of $822,000 were sold by WILENSKY GAIL R. BURKE RICHARD T sold $5.41 million worth of stock or 40,000 shares. WILSON D ELLEN had sold 14,365 shares worth $2.07M on Friday, October 21. Another trade for 3,000 shares valued at $453,615 was sold by BALLARD WILLIAM C JR. Shares for $47,121 were sold by Shine Kenneth Irwin.

More news for UnitedHealth Group Inc (NYSE:UNH) were recently published by:, which released: “UnitedHealth Group to Host Investor Conference” on November 21, 2016.‘s article titled: “December 9th Options Now Available For UnitedHealth Group (UNH)” and published on October 27, 2016 is yet another important article.

UNH Company Profile

UnitedHealth Group Incorporated, incorporated on January 25, 1977, is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various clients and markets. Optum is a health services business serving the health care marketplace, including payers, care providers, employers, Governments, life sciences companies and consumers. The Company’s business platforms have four divisions: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment